Cabozantinib in High Grade Neuroendocrine Neoplasms

NCT04412629 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

High Grade Neuroendocrine Neoplasms

Interventions

DRUG: Cabozantinib
PROCEDURE: Blood for plasma biomarkers
PROCEDURE: Tissue biopsy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]